Alexey L. Margolin
Founder at ALLENA PHARMACEUTICALS, INC.
Alexey L. Margolin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Chairman | 2019-01-31 | - |
| Founder | 2011-06-23 | - | |
| Director/Board Member | 2011-08-31 | 2019-01-31 | |
| Chief Executive Officer | 2011-08-31 | 2019-01-31 | |
| President | 2011-06-23 | 2017-01-31 | |
| Corporate Secretary | 2011-06-23 | 2019-01-31 | |
| Treasurer | 2011-06-23 | 2019-01-31 | |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Director/Board Member | - | - |
| Founder | 2011-08-31 | - | |
| Chief Executive Officer | 2011-08-31 | 2014-03-31 | |
| Chairman | 2014-03-31 | - | |
| President | 2011-08-31 | 2013-07-23 | |
Anagram Therapeutics, Inc.
 Anagram Therapeutics, Inc. Medical/Nursing ServicesHealth Services Anagram Therapeutics, Inc. provides healthcare services. The company is based in Framingham, MA. The CEO of the company is Robert Gallotto. | Chairman | - | - |
Career history of Alexey L. Margolin
Former positions of Alexey L. Margolin
| Companies | Position | Start | End |
|---|---|---|---|
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Chief Executive Officer | 2008-06-30 | 2010-11-30 |
| Founder | 2008-06-30 | 2010-11-30 | |
| President | 2008-06-30 | 2010-11-30 | |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 1992-12-31 | 2007-12-30 |
Training of Alexey L. Margolin
| Moscow University | Doctorate Degree |
Statistics
International
| United States | 6 |
| Russia | 2 |
Operational
| Chief Executive Officer | 3 |
| Chairman | 3 |
| Founder | 3 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |
Anagram Therapeutics, Inc.
Anagram Therapeutics, Inc. Medical/Nursing ServicesHealth Services Anagram Therapeutics, Inc. provides healthcare services. The company is based in Framingham, MA. The CEO of the company is Robert Gallotto. | Health Services |
- Stock Market
- Insiders
- Alexey L. Margolin
- Experience